MedPath

IBLASIN 40 MG/ML SUSPENSION ORAL

IBLASIN 40 MG/ML SUSPENSION ORAL

Pending
Register Number

66028

Prescription Type

Sin Receta

Authorization Date

Apr 14, 2004

Dosage Form

SUSPENSIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number66028
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

IBUPROFENOActive
Quantity: 4 g
Name: IBUPROFENO

ATC CLASSIFICATION (3)

M01A
M01AE
M01AE01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.